| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 21.137 | 191.111 | 135.097 | 63.894 | 67.242 | 46.603 |
| Total Income - EUR | - | - | - | - | 21.137 | 191.137 | 135.098 | 63.894 | 67.515 | 46.676 |
| Total Expenses - EUR | - | - | - | - | 18.669 | 164.683 | 130.022 | 78.446 | 63.361 | 46.326 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.468 | 26.454 | 5.076 | -14.551 | 4.153 | 350 |
| Net Profit/Loss - EUR | - | - | - | - | 1.834 | 24.605 | 3.094 | -15.843 | 3.380 | 260 |
| Employees | - | - | - | - | 0 | 1 | 2 | 1 | 0 | 0 |
Check the financial reports for the company - Dancri Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 5.212 | 25.807 | 28.169 | 26.372 |
| Current Assets | - | - | - | - | 6.654 | 32.651 | 15.009 | 22.090 | 18.047 | 16.270 |
| Inventories | - | - | - | - | 270 | 4.378 | 1.345 | 11.441 | 9.504 | 8.214 |
| Receivables | - | - | - | - | 3.446 | 9.778 | 6.091 | 10.415 | 8.396 | 7.970 |
| Cash | - | - | - | - | 2.938 | 18.495 | 7.573 | 234 | 147 | 85 |
| Shareholders Funds | - | - | - | - | 1.876 | 26.446 | 12.782 | -2.962 | 428 | 686 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 101 | 101 | 101 |
| Debts | - | - | - | - | 4.777 | 6.348 | 7.440 | 50.859 | 45.788 | 41.956 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Dancri Medical S.r.l.